Dr. Charlotte Jones-Burton is dedicated to creating healthier communities globally through drug development, patient advocacy and people engagement/empowerment. Her three-pronged approach reflect her personal values of community, service and health and wellness. Charlotte combines her leadership in research/drug and people development with her clinical acumen in order to positively impact the lives of patients and communities who suffer with chronic diseases. Charlotte is a pharmaceutical executive who has spent over a decade in the pharmaceutical industry leading clinical trial development for multiple medicines across various disease areas including cardiovascular and renal diseases. She is currently VP, Global Clinical Development, Nephrology at Otsuka Pharmaceutical Development & Commercialization, Inc. She earned a medical degree and Master of Science degree in Epidemiology and Preventive Medicine, with a concentration in Clinical Research, from the University of Maryland School of Medicine. Charlotte’s postgraduate training included an internal medicine residency and a nephrology fellowship at the University of Maryland Medical Systems. Charlotte is active in numerous professional associations and organizations and co-founded Women of Color in Pharma, a non-profit professional society focused on transforming the pharmaceutical landscape with women of color. As its President, Charlotte is leading the growth of the organization in the US and EU. Charlotte is the recipient of the 2020 NJ BIZ Best 50 Women in Business and was inducted in the MM&M 2020 Hall of Femme.